Adalimumab and Infliximab in Crohn’s disease - real life data from a national retrospective cohort study

ABSTRACT: Aim: to compare the efficacy and safety of Adalimumab(ADA) and Infliximab(IFX), in a large Romanian population and to identify predictors of response. Methods We performed a national retrospective cohort study including 265 patients (136 ADA, 129 IFX) between 2008-2014. Binary logistic reg...

Descripción completa

Detalles Bibliográficos
Autores principales: PREDA, C., FULGER, L., GHEORGHE, L., GHEORGHE, C., GOLDIS, A., TRIFAN, A., TANTAU, M., TANTAU, A., NEGREANU, L., MANUC, M., CIJEVSCHI-PRELIPCEAN, C., IACOB, R., TIERANU, C., MEIANU, C., DICULESCU, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256158/
https://www.ncbi.nlm.nih.gov/pubmed/30568821
http://dx.doi.org/10.12865/CHSJ.42.02.01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256158/
https://www.ncbi.nlm.nih.gov/pubmed/30568821
http://dx.doi.org/10.12865/CHSJ.42.02.01

Ejemplares similares